|
Since 2007, publications on corticosteroids used for acute respiratory distress syndrome have generally shown improvements in softer outcomes with early low to moderate doses. They've also shown that higher doses increase mortality. Guidelines have tacitly endorsed steroids for ARDS or simply avoided comment. However, two recent articles have thrust CS for ARDS back into the spotlight.
|